Sirnaomics, Inc
Gaithersburg, Maryland, US
Jul 08, 2021
Aug 02, 2021
Employment Type
Full time
Salary Type
Job Description
Sirnaomics, Inc. is a leading clinical stage biopharmaceutical company in the discovery and development of RNAi therapeutics for treatment of cancer and fibrotic diseases. We are seeking candidates to fill the newly created Scientist position focusing upon Biology in our headquarters in Gaithersburg, MD.

The successful candidate will participate in the Biology group effort to identify and evaluate nucleotide sequences for RNAi that can either kill/inhibit tumor cells or synergize with drugs to improve efficacy, which includes characterizing efficiency and specificity of newly developed targeted siRNA-delivery agents by cell imaging and functional assays, and then interpreting, evaluating the results as part of the planning process for subsequent studies.

To be considered for this position, the well qualified candidate will have a Bachelors' Degree (or equivalent) in Molecular or Cell Biology or similar discipline and at least 5 years of relevant experience in industry or academia. Candidates with an advanced degree (MA/MS/PhD) in Molecular or Cell Biology or similar discipline will be considered with 2 or more years of relevant experience in industry or academia. The preferred candidate will have hands-on experience in one or more of the following areas: mammalian cell cultures, nucleic acid extraction, quantification and RNA handling, qPCR techniques and analysis, western blotting/immuniblotting, cell imaging, and/or flow cytometry.

Sirnaomics is an Equal Opportunity Employer, and offers a fast paced/dynamic environment, growth opportunity, competitive compensation and a full benefits program.
Company DescriptionSirnaomics is a clinical stage biopharmaceutical company that is headquartered in Gaithersburg, MD, with offices in China, that develops novel drugs using chemically synthesized RNAi triggers (short interfering RNAs or siRNAs) delivered to the targeted cells within the body by proprietary peptide nanoparticle (PNP) formulations.